Showing results (491-500 of 518) with videos related to
Sort By:
Pageof 52
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 27, 2025
Functional Genomics Studies of Psychiatric Disorders in Individuals of Latin American Populations: A Scoping ReviewLuz M Porras, Isabelle Rodríguez-Lausell, Gabriel Iglesias-Maldonado, et al.Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|July 15, 2004
Dietetic guidelines: diet in secondary prevention of cardiovascular disease (first update, June 2003)L Hooper, E Griffiths, B Abrahams, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 16, 2026
Interplay between genetic ancestry, self-reported race and ethnicity, and clinical factors in pediatric acute lymphoblastic leukemia: A REDIAL Consortium ReportPragati Kore, Jennifer M Geris, Maria Leon-Camarena, et al.Pigment Cell & Melanoma Research|February 16, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodiesInes Pires da Silva, Isabella C Glitza, Lauren E Haydu, et al.Nature Genetics|September 18, 2025
Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effectsKonrad J Karczewski, Rahul Gupta, Masahiro Kanai, et al.JAMA Network Open|October 9, 2024
Psychological Distress Among Ethnically Diverse Participants From Eastern and Southern AfricaKester B B Tindi, Allan Kalungi, Eugene Kinyanda, et al.The Lancet. Oncology|April 15, 2021
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trialAlexander M M Eggermont, Christian U Blank, Mario Mandalà, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 TrialAlexander M M Eggermont, Christian U Blank, Mario Mandala, et al.European Journal of Cancer (Oxford, England : 1990)|June 15, 2019
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanomaAlexander M M Eggermont, Christian U Blank, Mario Mandala, et al.European Journal of Cancer (Oxford, England : 1990)|February 27, 2022
Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanomaOliver J Kennedy, Michal Kicinski, Sara Valpione, et al.Pageof 52